Analysis and Commentary STEVEN GROSSMAN 8/23/19 Analysis and Commentary STEVEN GROSSMAN 8/23/19 Sometimes Things Just Don't Go as Planned (or Hoped) Read More Advocacy at a Glance STEVEN GROSSMAN 8/23/19 Advocacy at a Glance STEVEN GROSSMAN 8/23/19 Appropriations Bills Face Unknown Fate in September Read More Analysis and Commentary STEVEN GROSSMAN 8/11/19 Analysis and Commentary STEVEN GROSSMAN 8/11/19 Angling for Optimism Read More Advocacy at a Glance STEVEN GROSSMAN 8/11/19 Advocacy at a Glance STEVEN GROSSMAN 8/11/19 BBA Becomes Law; Difficult Path to Appropriation Bills by October 1 Read More Analysis and Commentary STEVEN GROSSMAN 8/2/19 Analysis and Commentary STEVEN GROSSMAN 8/2/19 From Budget Deal to FY 20 Appropriations: Reasons for Optimism? Read More Advocacy at a Glance STEVEN GROSSMAN 8/2/19 Advocacy at a Glance STEVEN GROSSMAN 8/2/19 Budget Deal Passes Senate, President Agrees to Sign Read More Analysis and Commentary STEVEN GROSSMAN 7/26/19 Analysis and Commentary STEVEN GROSSMAN 7/26/19 A Budget Deal Seems to Be in Place ... But There Are More Questions Read More Advocacy at a Glance STEVEN GROSSMAN 7/26/19 Advocacy at a Glance STEVEN GROSSMAN 7/26/19 Budget Deal at Last: Resolves Top-Line Numbers for FY 20 and 21 Read More Analysis and Commentary STEVEN GROSSMAN 7/19/19 Analysis and Commentary STEVEN GROSSMAN 7/19/19 No Guarantees for a Bright Future Read More Advocacy at a Glance STEVEN GROSSMAN 7/19/19 Advocacy at a Glance STEVEN GROSSMAN 7/19/19 Put the Bubbly Back in the Fridge: No Budget Deal Quite Yet Read More Analysis and Commentary STEVEN GROSSMAN 7/12/19 Analysis and Commentary STEVEN GROSSMAN 7/12/19 Education and Advocacy for FDA Is a Year-Round Priority Read More Advocacy at a Glance STEVEN GROSSMAN 7/12/19 Advocacy at a Glance STEVEN GROSSMAN 7/12/19 House and Senate Action (or Lack) on FY 20 Appropriations Read More Analysis and Commentary STEVEN GROSSMAN 6/29/19 Analysis and Commentary STEVEN GROSSMAN 6/29/19 What CBO Had to Say about Our Long-term Fiscal Health Read More Advocacy at a Glance STEVEN GROSSMAN 6/29/19 Advocacy at a Glance STEVEN GROSSMAN 6/29/19 House Passes H.R. 3055, Including Ag/FDA Appropriations Read More Analysis and Commentary STEVEN GROSSMAN 6/24/19 Analysis and Commentary STEVEN GROSSMAN 6/24/19 Theory and Practice: How Appropriations Will Actually Work for FY 20 Read More Advocacy at a Glance STEVEN GROSSMAN 6/24/19 Advocacy at a Glance STEVEN GROSSMAN 6/24/19 Confused By the Budget and Appropriations Process? Read More Analysis and Commentary STEVEN GROSSMAN 5/31/19 Analysis and Commentary STEVEN GROSSMAN 5/31/19 The FY 20 Budget and BA Funding for FDA Isn't Going to Be Easy Read More Advocacy at a Glance STEVEN GROSSMAN 5/31/19 Advocacy at a Glance STEVEN GROSSMAN 5/31/19 House Appropriations To Move Quickly in June; Full-Committee Ag/FDA Mark-up on June 4 Read More Analysis and Commentary STEVEN GROSSMAN 5/23/19 Analysis and Commentary STEVEN GROSSMAN 5/23/19 House Mark-up for FY 20 Very Pleasing Read More Advocacy at a Glance STEVEN GROSSMAN 5/23/19 Advocacy at a Glance STEVEN GROSSMAN 5/23/19 House Subcommittee Proposes $184 million (6%) Increase for FDA’s FY 20 BA (Taxpayer) Funding Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 8/23/19 Analysis and Commentary STEVEN GROSSMAN 8/23/19 Sometimes Things Just Don't Go as Planned (or Hoped) Read More
Advocacy at a Glance STEVEN GROSSMAN 8/23/19 Advocacy at a Glance STEVEN GROSSMAN 8/23/19 Appropriations Bills Face Unknown Fate in September Read More
Analysis and Commentary STEVEN GROSSMAN 8/11/19 Analysis and Commentary STEVEN GROSSMAN 8/11/19 Angling for Optimism Read More
Advocacy at a Glance STEVEN GROSSMAN 8/11/19 Advocacy at a Glance STEVEN GROSSMAN 8/11/19 BBA Becomes Law; Difficult Path to Appropriation Bills by October 1 Read More
Analysis and Commentary STEVEN GROSSMAN 8/2/19 Analysis and Commentary STEVEN GROSSMAN 8/2/19 From Budget Deal to FY 20 Appropriations: Reasons for Optimism? Read More
Advocacy at a Glance STEVEN GROSSMAN 8/2/19 Advocacy at a Glance STEVEN GROSSMAN 8/2/19 Budget Deal Passes Senate, President Agrees to Sign Read More
Analysis and Commentary STEVEN GROSSMAN 7/26/19 Analysis and Commentary STEVEN GROSSMAN 7/26/19 A Budget Deal Seems to Be in Place ... But There Are More Questions Read More
Advocacy at a Glance STEVEN GROSSMAN 7/26/19 Advocacy at a Glance STEVEN GROSSMAN 7/26/19 Budget Deal at Last: Resolves Top-Line Numbers for FY 20 and 21 Read More
Analysis and Commentary STEVEN GROSSMAN 7/19/19 Analysis and Commentary STEVEN GROSSMAN 7/19/19 No Guarantees for a Bright Future Read More
Advocacy at a Glance STEVEN GROSSMAN 7/19/19 Advocacy at a Glance STEVEN GROSSMAN 7/19/19 Put the Bubbly Back in the Fridge: No Budget Deal Quite Yet Read More
Analysis and Commentary STEVEN GROSSMAN 7/12/19 Analysis and Commentary STEVEN GROSSMAN 7/12/19 Education and Advocacy for FDA Is a Year-Round Priority Read More
Advocacy at a Glance STEVEN GROSSMAN 7/12/19 Advocacy at a Glance STEVEN GROSSMAN 7/12/19 House and Senate Action (or Lack) on FY 20 Appropriations Read More
Analysis and Commentary STEVEN GROSSMAN 6/29/19 Analysis and Commentary STEVEN GROSSMAN 6/29/19 What CBO Had to Say about Our Long-term Fiscal Health Read More
Advocacy at a Glance STEVEN GROSSMAN 6/29/19 Advocacy at a Glance STEVEN GROSSMAN 6/29/19 House Passes H.R. 3055, Including Ag/FDA Appropriations Read More
Analysis and Commentary STEVEN GROSSMAN 6/24/19 Analysis and Commentary STEVEN GROSSMAN 6/24/19 Theory and Practice: How Appropriations Will Actually Work for FY 20 Read More
Advocacy at a Glance STEVEN GROSSMAN 6/24/19 Advocacy at a Glance STEVEN GROSSMAN 6/24/19 Confused By the Budget and Appropriations Process? Read More
Analysis and Commentary STEVEN GROSSMAN 5/31/19 Analysis and Commentary STEVEN GROSSMAN 5/31/19 The FY 20 Budget and BA Funding for FDA Isn't Going to Be Easy Read More
Advocacy at a Glance STEVEN GROSSMAN 5/31/19 Advocacy at a Glance STEVEN GROSSMAN 5/31/19 House Appropriations To Move Quickly in June; Full-Committee Ag/FDA Mark-up on June 4 Read More
Analysis and Commentary STEVEN GROSSMAN 5/23/19 Analysis and Commentary STEVEN GROSSMAN 5/23/19 House Mark-up for FY 20 Very Pleasing Read More
Advocacy at a Glance STEVEN GROSSMAN 5/23/19 Advocacy at a Glance STEVEN GROSSMAN 5/23/19 House Subcommittee Proposes $184 million (6%) Increase for FDA’s FY 20 BA (Taxpayer) Funding Read More
